Literature DB >> 29725554

Distinct Evening Fatigue Profiles in Oncology Outpatients Receiving Chemotherapy.

Fay Wright1, Bruce A Cooper2, Yvette P Conley3, Marilyn J Hammer4, Lee-May Chen5, Steven M Paul2, Jon D Levine5, Christine Miaskowski2, Kord M Kober2.   

Abstract

BACKGROUND: Fatigue is the most common and debilitating symptom experienced by oncology patients during chemotherapy (CTX). Fatigue severity demonstrates a large amount of inter-individual and diurnal variability.
PURPOSE: Study purposes were to evaluate for subgroups of patients with distinct evening fatigue profiles and evaluate how these subgroups differed on demographic, clinical, and symptom characteristics.
METHODS: Outpatients with breast, gastrointestinal, gynecological, or lung cancer (n=1332) completed questionnaires six times over two cycles of CTX. Lee Fatigue Scale (LFS) evaluated evening fatigue severity. Latent profile analysis was used to identify distinct evening fatigue profiles.
RESULTS: Four distinct evening fatigue classes (i.e., Low (14.0%), Moderate (17.2%), High (36.0%), Very High (32.8%)) were identified. Compared to the Low class, patients in the Very High evening fatigue class were: younger, female, had childcare responsibilities, had more years of education, had a lower functional status, had a higher comorbidity burden, and were diagnosed with breast cancer. Patients in the Very High class reported higher levels of depressive symptoms, sleep disturbance, and evening fatigue at enrollment.
CONCLUSIONS: Findings provide new insights into modifiable risk factors for higher levels of evening fatigue. Clinicians can use this information to identify higher risk patients and plan appropriate interventions.

Entities:  

Keywords:  chemotherapy; diurnal variations; evening fatigue; latent class analysis; symptom profiles

Year:  2017        PMID: 29725554      PMCID: PMC5926814          DOI: 10.1080/21641846.2017.1322233

Source DB:  PubMed          Journal:  Fatigue        ISSN: 2164-1846


  49 in total

1.  Self-reported sleep disturbances in employed women.

Authors:  K A Lee
Journal:  Sleep       Date:  1992-12       Impact factor: 5.849

2.  The Attentional Function Index--a self-report cognitive measure.

Authors:  Bernadine Cimprich; Moira Visovatti; David L Ronis
Journal:  Psychooncology       Date:  2011-02       Impact factor: 3.894

3.  Polymorphisms in Cytokine Genes Are Associated With Higher Levels of Fatigue and Lower Levels of Energy in Women After Breast Cancer Surgery.

Authors:  Kord M Kober; Betty Smoot; Steven M Paul; Bruce A Cooper; Jon D Levine; Christine Miaskowski
Journal:  J Pain Symptom Manage       Date:  2016-09-21       Impact factor: 3.612

4.  Age differences in fatigue, decrements in energy, and sleep disturbance in oncology patients receiving chemotherapy.

Authors:  Lindsey E Bischel; Christine Ritchie; Kord M Kober; Steven M Paul; Bruce A Cooper; Lee-May Chen; Jon D Levine; Marilyn Hammer; Fay Wright; Christine Miaskowski
Journal:  Eur J Oncol Nurs       Date:  2016-07-15       Impact factor: 2.398

5.  Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases.

Authors:  R L Daut; C S Cleeland; R C Flanery
Journal:  Pain       Date:  1983-10       Impact factor: 6.961

Review 6.  Cancer-related fatigue and its associations with depression and anxiety: a systematic review.

Authors:  Linda F Brown; Kurt Kroenke
Journal:  Psychosomatics       Date:  2009 Sep-Oct       Impact factor: 2.386

7.  Longitudinal relationships between fatigue and depression in cancer patients with depression and/or pain.

Authors:  Linda F Brown; Kevin L Rand; Silvia M Bigatti; Jesse C Stewart; Dale E Theobald; Jingwei Wu; Kurt Kroenke
Journal:  Health Psychol       Date:  2012-08-27       Impact factor: 4.267

8.  Screening, assessment, and management of fatigue in adult survivors of cancer: an American Society of Clinical oncology clinical practice guideline adaptation.

Authors:  Julienne E Bower; Kate Bak; Ann Berger; William Breitbart; Carmelita P Escalante; Patricia A Ganz; Hester Hill Schnipper; Christina Lacchetti; Jennifer A Ligibel; Gary H Lyman; Mohammed S Ogaily; William F Pirl; Paul B Jacobsen
Journal:  J Clin Oncol       Date:  2014-04-14       Impact factor: 44.544

9.  Magnitude and correlates of response shift in fatigue ratings in women undergoing adjuvant therapy for breast cancer.

Authors:  Michael A Andrykowski; Kristine A Donovan; Paul B Jacobsen
Journal:  J Pain Symptom Manage       Date:  2008-08-30       Impact factor: 3.612

10.  Variability of patterns of fatigue and quality of life over time based on different breast cancer adjuvant chemotherapy regimens.

Authors:  Ann M Berger; Kari Lockhart; Sangeeta Agrawal
Journal:  Oncol Nurs Forum       Date:  2009-09       Impact factor: 2.172

View more
  3 in total

1.  Distinct profiles of multiple co-occurring symptoms in patients with gastrointestinal cancers receiving chemotherapy.

Authors:  Yufen Lin; Donald E Bailey; Sharron L Docherty; Laura S Porter; Bruce A Cooper; Steven M Paul; Kord M Kober; Marilyn J Hammer; Fay Wright; Laura B Dunn; Yvette P Conley; Jon D Levine; Christine Miaskowski
Journal:  Support Care Cancer       Date:  2021-01-16       Impact factor: 3.359

2.  Prediction of evening fatigue severity in outpatients receiving chemotherapy: less may be more.

Authors:  Kord M Kober; Ritu Roy; Anand Dhruva; Yvette P Conley; Raymond J Chan; Bruce Cooper; Adam Olshen; Christine Miaskowski
Journal:  Fatigue       Date:  2021-02-16

3.  Higher levels of stress and different coping strategies are associated with greater morning and evening fatigue severity in oncology patients receiving chemotherapy.

Authors:  Fay Wright; Kord M Kober; Bruce A Cooper; Steven M Paul; Yvette P Conley; Marilyn Hammer; Jon D Levine; Christine Miaskowski
Journal:  Support Care Cancer       Date:  2020-01-20       Impact factor: 3.603

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.